NSAC: Kurt Holobaugh used illegal IV prior to Dana White's Contender Series 1 win

Kurt Holobaugh’s reported UFC contract offer could be on hold.

The Nevada State Athletic Commission has filed a disciplinary complaint against the featherweight, alleging he used an illegal IV following the weigh-ins for “Dana White’s Contender Series 1” in July.

Holobaugh (18-4) now faces a suspension ranging from nine months to two years. He also faces a fine and the overturning of his first-round knockout win over Matt Bessette (22-8). His case goes before the NSAC during its Tuesday meeting in Las Vegas.

The possible punishment won’t go uncontested. Holobaugh’s manager, Brian Butler, disputed the commission’s findings and said the fighter will comment soon.

According to NSAC Management Analyst Nyra Phillips, Holobaugh allegedly received an intravenous injection of more than 50 milliliters “per six hour period” after the event’s July 10 weigh-ins. The injection wasn’t part of a hospital procedure or surgical procedure, and Holobaugh didn’t notify the commission or receive a therapeutic-use exemption, she added.

“We have allowances for when you can have (an IV), and this did not fit into any of those allowances,” she told MMAjunkie. “When it’s more than 50 milliliters per six-hour period, it becomes a prohibited method per the (World Anti-Doping Agency) list.”

The NSAC overhauled its drug testing program in 2015, implementing harsher punishments for anti-doping offenses and repeat offenders. A new schedule of potential punishments went into effect in September 2016.

At the time of his knockout, Holobaugh reportedly was offered a UFC contract. It was his fourth straight win.

For more on the UFC’s upcoming schedule, check out the UFC Rumors section of the site.